- The Hospital Atrial Fibrillation Market Guide
- The Hospital Anticoagulant Market Guide
The Hospital Atrial Fibrillation Market Guide
The Hospital Atrial Fibrillation Market Guide is a comprehensive audit of inpatient atrial fibrillation therapy. It presents clinical usage patterns and provides clinical utilization details for type I and III antiarrhythmic and electrical cardioversion therapies for atrial fibrillation in the hospital marketplace. Patient shares, grams administered, days of therapy and many other invaluable parameters necessary for the evaluation of atrial fibrillation therapy are included. The European audits, covering Germany, Italy, France, U.K. and Spain are available quarterly.
The Hospital Anticoagulant Market Guide
The Hospital Anticoagulant Market Guide is a comprehensive and detailed audit of anticoagulant drug usage in acute care hospitals. It presents clinical usage patterns and provides clinical utilization details for the drugs comprising the hospital anticoagulant marketplace. Patient shares, grams administered, days of therapy and many other invaluable parameters necessary for the evaluation of inpatient anticoagulant use are included. The usage of anticoagulants by indication is quantified and includes use for atrial fibrillation, deep vein thrombosis prophylaxis and acute coronary syndrome. The European audits, covering Germany, Italy, France, U.K. and Spain are available every October.